Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;74(10):1305-1319.
doi: 10.1111/anae.14757. Epub 2019 Jul 25.

International consensus statement on the use of uterotonic agents during caesarean section

M Heesen  1 , B Carvalho  2 , J C A Carvalho  3 , J J Duvekot  4 , R A Dyer  5 , D N Lucas  6 , N McDonnell  7 , S Orbach-Zinger  8 , S M Kinsella  9
Affiliations
Free article

International consensus statement on the use of uterotonic agents during caesarean section

M Heesen et al. Anaesthesia. 2019 Oct.
Free article

Abstract

It is routine to give a uterotonic drug following delivery of the neonate during caesarean section. However, there is much heterogeneity in the relevant research, which has largely been performed in low-risk elective cases or women with uncomplicated labour. This is reflected in considerable variation in clinical practice. There are significant differences between dose requirements during elective and intrapartum caesarean section. Standard recommended doses are higher than required, with the potential for acute cardiovascular adverse effects. We recommend a small initial bolus dose of oxytocin, followed by a titrated infusion. The recommended doses of oxytocin may have to be increased in women with risk factors for uterine atony. Carbetocin at equipotent doses to oxytocin has similar actions, while avoiding the requirement for a continuous infusion after the initial dose and reducing the need for additional uterotonics. As with oxytocin, carbetocin dose requirements are higher for intrapartum caesarean sections. A second-line agent should be considered early if oxytocin/carbetocin fails to produce good uterine tone. Women with cardiac disease may be very sensitive to the adverse effects of oxytocin and other uterotonics, and their management needs to be individualised.

Keywords: caesarean section; carbetocin; haemorrhage, obstetric; oxytocin; uterus, tone.

PubMed Disclaimer

Comment in

References

    1. Gutkowska J, Jankowski M. Oxytocin revisited: its role in cardiovascular regulation. Journal of Neuroendocrinology 2012; 24: 599-608.
    1. Lewis G, ed. Why mothers die 1997-99. The confidential enquiry into maternal deaths in the United Kingdom. London, UK: RCOG Press, 2001.
    1. Farina Z, Fawcus S. Oxytocin-ensuring appropriate use and balancing efficacy with safety. South African Medical Journal 2015; 105: 271-4.
    1. Mavrides E, Allard S, Chandraharan E, et al. on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 2016; 124: e106-49.
    1. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstetrics and Gynecology 2017; 130: e168-86.